Ncage Therapeutics S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Rental and Leasing Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services | All Other Miscellaneous Ambulatory Health Care Services | Administration of Economic Programs

Full name: Ncage Therapeutics S.A.

Profile Updated: December 10, 2025

Ncage Therapeutics S.A. is based in Poland. The head office is in Krakow. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. Ncage Therapeutics S.A. was incorporated on July 25, 2024.

Headquarters
Ul. Profesora Michala Bobrzynskiego 14
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the Ncage Therapeutics S.A. report to view the information.

Website: http://www.ncage.org

Basic Information

Registered Capital:

Purchase the Ncage Therapeutics S.A. report to view the information.

Financial Auditors:

Purchase the Ncage Therapeutics S.A. report to view the information.

Incorporation Date:

July 25, 2024

Key Executives